ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

BASF Pushes Further Into Omega-3 Market

by Alex Scott
November 26, 2012 | APPEARED IN VOLUME 90, ISSUE 48

BASF has agreed to purchase Pronova BioPharma, a Norwegian producer of omega-3 fatty acids from fish oil, for $850 million. BASF says it has secured commitments from venture capital shareholders for approximately 60% of Pronova. The company’s omega-3-based compounds are used in nutritional supplements and in an FDA-approved drug for cardiovascular disease. Last year Pronova had concentrated omega-3 production capacity of 2,500 metric tons per year and sales of about $300 million. “We want to combine the global market reach and experience of BASF with the know-how of Pronova in omega-3 fatty acids,” BASF says. BASF, which is also developing plant-derived omega-3 fatty acids, purchased a small Scottish omega-3 producer in May. Also in May, DSM agreed to acquire the omega-3 company Ocean Nutrition Canada for $530 million.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment